✦ LIBER ✦

Phase II study of biweekly administration of docetaxel and irinotecan in patients with refractory or relapsed advanced non-small cell lung cancer

✍ Scribed by Takashi Hirose; Takao Shirai; Hiroo Ishida; Kohichi Ando; Tomohide Sugiyama; Sojiro Kusumoto; Takamichi Hosaka; Masanao Nakashima; Tohru Ohmori; Mitsuru Adachi

Publisher: Springer
Year: 2007
Tongue: English
Weight: 312 KB
Volume: 60
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-006-0369-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biweekly docetaxel-irinotecan with filgr

Biweekly docetaxel-irinotecan with filgrastim support in pretreated breast and non-small-cell lung cancer patients. A phase I study

✍ Giuseppe Frasci; Pasquale Comella; Renato Thomas; Maurizio Bonito; Liliana Lapen 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 197 KB

Phase II study of carboplatin combined w

Phase II study of carboplatin combined with weekly docetaxel in patients with advanced non-small cell lung cancer

✍ Lian Jiang; Dao-yuan Wang; Zhi-hua Zhu; Liang-fa Tang; Xin-heng Hou; Hong-da Zha 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 242 KB

Phase II study of weekly docetaxel combi

Phase II study of weekly docetaxel combined with cisplatin in patients with advanced non-small-cell lung cancer

✍ Toshiyuki Tsunoda; Tomonobu Koizumi; Muneharu Hayasaka; Kazuya Hirai; Shigeru Ko 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 180 KB

Phase 2 study of irinotecan and paclitax

Phase 2 study of irinotecan and paclitaxel in patients with recurrent or refractory small cell lung cancer

✍ Suresh S. Ramalingam; Judy Foster; William Gooding; Terry Evans; Matthew Sulecki 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

Phase II study with fractionated schedul

Phase II study with fractionated schedule of docetaxel and cisplatin in patients with advanced non-small cell lung cancer

✍ Jung Hye Kwon; Jung Han Kim; Jung-Ae Lee; Hyun Chun Shin; Hyo Jung Kim; Hun Ho S 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 193 KB

Phase II study of S-1, a novel oral fluo

Phase II study of S-1, a novel oral fluoropyrimidine, and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancer

✍ Yasunari Oki; Takashi Hirose; Toshimitsu Yamaoka; Sojiro Kusumoto; Takao Shirai; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 268 KB